Measles in Democratic Republic of Congo: an outbreak description from Katanga, 2010–2011

BMC Infectious Diseases

Klaudia Porten¹  Rebecca F Grais¹  Francisco J Luquero¹  Alexandra N’Goran¹  Jean de Dieu Ilunga Ngoie⁴  Géza Harczi³  Anne Chatelain²  Florence Fermon²  Gwenola François²  Northan Hurtado²  Andrea Minetti¹  Lise Grout¹ 

[1] Epicentre, Paris, France;Médecins Sans Frontières, Paris, France;Médecins Sans Frontières, Lubumbashi, Democratic Republic of Congo;Ministry of Health, Lubumbashi, Democratic Republic of Congo

关键词: Control;    Africa south of the sahara;    Mass vaccination;    Disease outbreak;    Measles;   

Others  :  1148299
DOI  :  10.1186/1471-2334-13-232

 received in 2012-11-18, accepted in 2013-05-14,  发布年份 2013

【 摘 要 】

Background

The Democratic Republic of Congo experiences regular measles outbreaks. From September 2010, the number of suspected measles cases increased, especially in Katanga province, where Medecins sans Frontieres supported the Ministry of Health in responding to the outbreak by providing free treatment, reinforcing surveillance and implementing non-selective mass vaccination campaigns. Here, we describe the measles outbreak in Katanga province in 2010–2011 and the results of vaccine coverage surveys conducted after the mass campaigns.

Methods

The surveillance system was strengthened in 28 of the 67 health zones of the province and we conducted seven vaccination coverage surveys in 2011.

Results

The overall cumulative attack rate was 0.71% and the case fatality ratio was 1.40%.

The attack rate was higher in children under 4 and decreased with age. This pattern was consistent across districts and time. The number of cases aged 10 years and older barely increased during the outbreak.

Conclusions

Early investigation of the age distribution of cases is a key to understanding the epidemic, and should guide the vaccination of priority age groups.

【 授权许可】

   
2013 Grout et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]African region: Progress toward measles control - African region, 2001–2008. MMWR Morb Mortal Wkly Rep 2009, 58(37):1036-1041.
• [2]WHO African Region: Measles outbreaks and progress towards meeting measles pre-elimination goals. Wkly Epidemiol Rec 2011, 86(14):129-136.
• [3]Ministry of Health of Democratic Republic of Congo: Follow-up campaign against measles, action plan 2010. 2012.
• [4]Philippon S: Measles outbreak in Democratic Republic of Congo, Tanganyika district, 2007–2008. Democratic Republic of Congo: Epicentre/MSF; 2008.
• [5]World Health Organization: Response to measles outbreaks in measles mortality reduction settings. Geneva, Switzerland: World Health Organization; 2009. [http://whqlibdoc.who.int/hq/2009/WHO_IVB_09.03_eng.pdf webcite]
• [6]Center for Disease Control and Prevention, World Health Organization: Technical guidelines for Integrated Disease Surveillance and Response in the African Region. Brazzaville: Republic of Congo and Atlanta, USA; 2010. [http://www.cdc.gov/globalhealth/dphswd/idsr/tools/guidelines.html webcite]
• [7]Ministère du Plan, Macro International: Demographic and Health Survey, Democratic Republic of Congo, 2007. Calverton, Maryland, USA; 2008.
• [8]Luquero FJ, Pham-Orsetti H, Cummings DA, Ngaunji PE, Nimpa M, Fermon F, et al.: A long-lasting measles epidemic in Maroua, Cameroon 2008–2009: mass vaccination as response to the epidemic. J Infect Dis 2011, 204(Suppl 1):S243-S251.
• [9]World Health Organization: Immunization coverage cluster survey - Reference manual. Geneva, Switzerland: World Health Organization; 2005. [http://whqlibdoc.who.int/hq/2005/WHO_IVB_04.23.pdf webcite]
• [10]Alberti KP, King LA, Burny M-E, Kebela Ilunga B, Grais RF: Reactive vaccination as an effective tool for measles outbreak control in measles mortality reduction settings, Democratic Republic of Congo, 2005–2006. International Health 2010, 2:65-68.
• [11]Guerrier G, Guerra J, Fermon F, Talkibing WB, Sekkenes J, Grais RF: Outbreak response immunisation: the experience of Chad during recurrent measles epidemics in 2005 and 2010. International Health 2011, 3:226-230.
• [12]Minetti A, Kagoli M, Katsulukuta A, Featherstone A, Huerga H, Chiotcha H, et al.: Lessons and challenges for measles control from an unexpected large outbreak in Malawi. Emerg Infect Dis 2013, 19(2):202-209.
• [13]Grais RF, DE RX, Dubray C, Fermon F, Guerin PJ, Dubray C, Fermon F, Guerin PJ: Exploring the time to intervene with a reactive mass vaccination campaign in measles epidemics. Epidemiol Infect 2006, 134(4):845-849.
• [14]Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM: Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol 2009, 38(1):192-205.
• [15]World Health Organization: Report of the second meeting of the African regional measles technical advisory group (TAG), recommendations. Addis Ababa, Ethiopia: World Health Organization, Regional Office for Africa; 2008. [http://www.afro.who.int/index.php?option=com_docman&task=doc_download&gid=3616 webcite]
• [16]WHO: position on measles vaccines. Vaccine 2009, 9;27(52):7219-7221.
• [17]Samb B, Aaby P, Whittle H, Seck AM, Simondon F: Decline in measles case fatality ratio after the introduction of measles immunization in rural Senegal. Am J Epidemiol 1997, 1;145(1):51-57.